Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) were down 2.3% during mid-day trading on Friday . The company traded as low as $1.64 and last traded at $1.69. Approximately 25,346 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 62,169,492 shares. The stock had previously closed at $1.73.
BioRestorative Therapies Price Performance
The firm’s fifty day moving average price is $1.73 and its 200-day moving average price is $1.73. The company has a market cap of $2.77 billion, a price-to-earnings ratio of -1.58 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- What Are Dividend Champions? How to Invest in the Champions
- Short Sellers Gave Up on These 3 Names Recently
- Best Stocks Under $10.00
- 3 Boring Stocks Outperforming the Market This Year
- Financial Services Stocks Investing
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
